Literature DB >> 31743999

Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEɛ4 Carriers.

Chelsea C Hays1,2, Zvinka Z Zlatar3,2, M J Meloy1, Jessica Osuna1,3, Thomas T Liu4, Douglas R Galasko1,5, Christina E Wierenga1,3,2.   

Abstract

Evidence suggests the ɛ4 allele of the apolipoprotein E (APOE) gene may accelerate an age-related process of cortical thickening and cerebral blood flow (CBF) reduction in the anterior cingulate cortex (ACC). Although the neural basis of this association remains unclear, evidence suggests it might reflect early neurodegenerative processes. However, to date, associations between cerebrospinal fluid (CSF) biomarkers of neurodegeneration, such as CSF tau, and APOE-related alterations in ACC cortical thickness (CTH) and CBF have yet to be explored. The current study explored the interaction of CSF tau and APOE genotype (ɛ4+, ɛ4-) on FreeSurfer-derived CTH and arterial spin labeling MRI-measured resting CBF in the ACC (caudal ACC [cACC] and rostral ACC [rACC]) among a sample of 45 cognitively normal older adults. Secondary analyses also examined associations between APOE, CTH/CBF, and cognitive performance. In the cACC, higher CSF tau was associated with higher CTH and lower CBF in ɛ4+, whereas these relationships were not evident in ɛ4-. In the rACC, higher CSF tau was associated with higher CTH for both ɛ4+ and ɛ4-, and with lower CBF only in ɛ4+. Significant interactions of CSF tau and APOE on CTH/CBF were not observed in two posterior reference regions implicated in Alzheimer's disease. Secondary analyses revealed a negative relationship between cACC CTH and executive functioning in ɛ4+ and a positive relationship in ɛ4-. Findings suggest the presence of an ɛ4-related pattern of increased CTH and reduced CBF in the ACC that is associated with biomarkers of neurodegeneration and subtle decrements in cognition.

Entities:  

Keywords:  APOE; Aging; Alzheimer’s disease; cerebral blood flow; cognition; cognitive decline; grey matter; magnetic resonance imaging; tau proteins

Mesh:

Substances:

Year:  2020        PMID: 31743999      PMCID: PMC7310575          DOI: 10.3233/JAD-190504

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  81 in total

1.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.

Authors:  P Giannakopoulos; F R Herrmann; T Bussière; C Bouras; E Kövari; D P Perl; J H Morrison; G Gold; P R Hof
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

2.  A signal processing model for arterial spin labeling functional MRI.

Authors:  Thomas T Liu; Eric C Wong
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

3.  In vivo method for correcting transmit/receive nonuniformities with phased array coils.

Authors:  Jinghua Wang; Maolin Qiu; R Todd Constable
Journal:  Magn Reson Med       Date:  2005-03       Impact factor: 4.668

4.  Aging in the CNS: comparison of gray/white matter volume and diffusion tensor data.

Authors:  Osamu Abe; Hidenori Yamasue; Shigeki Aoki; Motomu Suga; Haruyasu Yamada; Kiyoto Kasai; Yoshitaka Masutani; Nobuyuki Kato; Nobumasa Kato; Kuni Ohtomo
Journal:  Neurobiol Aging       Date:  2006-10-04       Impact factor: 4.673

5.  AFNI: software for analysis and visualization of functional magnetic resonance neuroimages.

Authors:  R W Cox
Journal:  Comput Biomed Res       Date:  1996-06

6.  Accelerating cortical thinning: unique to dementia or universal in aging?

Authors:  Anders M Fjell; Lars T Westlye; Håkon Grydeland; Inge Amlien; Thomas Espeseth; Ivar Reinvang; Naftali Raz; Anders M Dale; Kristine B Walhovd
Journal:  Cereb Cortex       Date:  2012-12-12       Impact factor: 5.357

7.  CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects.

Authors:  Michael Ewers; Philip Insel; William J Jagust; Leslie Shaw; John Q Trojanowski; Paul Aisen; Ronald C Petersen; Norbert Schuff; Michael W Weiner
Journal:  Cereb Cortex       Date:  2011-10-29       Impact factor: 5.357

8.  Distinct genetic influences on cortical surface area and cortical thickness.

Authors:  Matthew S Panizzon; Christine Fennema-Notestine; Lisa T Eyler; Terry L Jernigan; Elizabeth Prom-Wormley; Michael Neale; Kristen Jacobson; Michael J Lyons; Michael D Grant; Carol E Franz; Hong Xian; Ming Tsuang; Bruce Fischl; Larry Seidman; Anders Dale; William S Kremen
Journal:  Cereb Cortex       Date:  2009-03-18       Impact factor: 5.357

9.  APOE ε4 increases risk for dementia in pure synucleinopathies.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

10.  Interaction of age and APOE genotype on cerebral blood flow at rest.

Authors:  Christina E Wierenga; Lindsay R Clark; Sheena I Dev; David D Shin; Sarah M Jurick; Robert A Rissman; Thomas T Liu; Mark W Bondi
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more
  2 in total

Review 1.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

2.  Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum.

Authors:  Anna Rubinski; Duygu Tosun; Nicolai Franzmeier; Julia Neitzel; Lukas Frontzkowski; Michael Weiner; Michael Ewers
Journal:  Neurobiol Aging       Date:  2021-02-10       Impact factor: 5.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.